Dexter Yan - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Dexter Yan's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Dexter Yan
Verified
Senior Reporter, Citeline
Shanghai Shi
Beats
covid19, Immunotherapy , Public Health, Cancer, Health Care Policy , Immunology
reality television, recipes, restaurant reviews
Content
By Andrew McConaghie Verified, Edwin Elmhirst Verified, Dexter Yan Verified| Scrip Verified China’s Biotech Stocks Proved More Resilient Than US Amid Market TurmoilStart-ups from China dominated the fastest-growing share prices for mid-cap biopharma companies in Q1, while the biggest decliners were mainly US firms.
By Dexter Yan Verified| Scrip Verified Henlius In David Versus Goliath Race With Pfizer For First PD-L1 ADC While Henlius Biotech’s PD-L1-targeting antibody-drug conjugate HLX43 is struggling to catch up with Pfizer’s PF-08046054, the global frontrunner in the space, a key differentiation of the China-originated asset could lie in PD-L1-negative patients. Henlius’ HLX43 is the second most advanced in the class of PD-L1-targeting ADCs globally, after Pfizer's PDL1V. (Shutterstock)
By Andrew McConaghie Verified, Edwin Elmhirst Verified, Dexter Yan Verified| Scrip Verified China’s Biotech Stocks Proved More Resilient Than US Amid Market TurmoilStart-ups from China dominated the fastest-growing share prices for mid-cap biopharma companies in Q1, while the biggest decliners were mainly US firms.
Company Info
Citeline
Citeline, part of Norstella, is a global leader in pharmaceutical and medtech business intelligence solutions. The company is dedicated to connecting treatments with patients by providing data-driven insights across clinical, commercial, and regulatory areas. Its mission is to ensure timely access to treatments through evidence-based decision-making tools. Citeline offers a range of specialized solutions, including real-time R&D intelligence, regulatory compliance support, and in-depth analysis of industry trends. Their clinical solutions provide global clinical trial data and tools for protocol design and enrollment benchmarking. Additionally, Citeline enhances patient engagement and recruitment through awareness campaigns and educational resources. The company serves over 180,000 users worldwide, including pharmaceutical companies, biotech firms, and clinical research organizations, supporting professionals throughout the drug development lifecycle. With a global team of analysts and consultants, Citeline curates valuable insights on key diseases and market forecasts, emphasizing a patient-centric approach to address challenges in clinical trials and market competition.
'+1 646-957-8919
Founded: 1997